These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34462559)

  • 1. The role of vitamin C in pneumonia and COVID-19 infection in adults with European ancestry: a Mendelian randomisation study.
    Hui LL; Nelson EAS; Lin SL; Zhao JV
    Eur J Clin Nutr; 2022 Apr; 76(4):588-591. PubMed ID: 34462559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
    PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically predicted serum vitamin D and COVID-19: a Mendelian randomisation study.
    Patchen BK; Clark AG; Gaddis N; Hancock DB; Cassano PA
    BMJ Nutr Prev Health; 2021; 4(1):213-225. PubMed ID: 34308129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Circulating Zinc, Selenium, Copper and Vitamin K
    Sobczyk MK; Gaunt TR
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057415
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.
    Wang H; Guo Z; Zheng Y; Chen B
    BMC Cardiovasc Disord; 2022 Jun; 22(1):262. PubMed ID: 35690714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.
    Cui Z; Tian Y
    J Transl Med; 2021 Jul; 19(1):300. PubMed ID: 34246301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.
    Liu H; Zhang Y; Zhang H; Wang L; Wang T; Han Z; Wu L; Liu G
    J Transl Med; 2021 May; 19(1):221. PubMed ID: 34030714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically predicted circulating vitamin C in relation to cardiovascular disease.
    Yuan S; Zheng JS; Mason AM; Burgess S; Larsson SC
    Eur J Prev Cardiol; 2022 Jan; 28(16):1829-1837. PubMed ID: 34057996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between COVID-19 and telomere length: A bidirectional Mendelian randomization study.
    Huang D; Lin S; He J; Wang Q; Zhan Y
    J Med Virol; 2022 Nov; 94(11):5345-5353. PubMed ID: 35854470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
    Zheng J; Zhang Y; Zhao H; Liu Y; Baird D; Karim MA; Ghoussaini M; Schwartzentruber J; Dunham I; Elsworth B; Roberts K; Compton H; Miller-Molloy F; Liu X; Wang L; Zhang H; Smith GD; Gaunt TR
    EBioMedicine; 2022 Jul; 81():104112. PubMed ID: 35772218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK Biobank.
    Li X; van Geffen J; van Weele M; Zhang X; He Y; Meng X; Timofeeva M; Campbell H; Dunlop M; Zgaga L; Theodoratou E
    Sci Rep; 2021 Sep; 11(1):18262. PubMed ID: 34521884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating vitamin C and digestive system cancers: Mendelian randomization study.
    Larsson SC; Mason AM; Vithayathil M; Carter P; Kar S; Zheng JS; Burgess S
    Clin Nutr; 2022 Sep; 41(9):2031-2035. PubMed ID: 35986965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Plasma Vitamin C and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization Study.
    Chen S; Zheng C; Chen T; Huang D; Pan Y; Chen S
    Front Med (Lausanne); 2022; 9():844228. PubMed ID: 35355592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational Attainment Decreases the Risk of COVID-19 Severity in the European Population: A Two-Sample Mendelian Randomization Study.
    Yoshikawa M; Asaba K
    Front Public Health; 2021; 9():673451. PubMed ID: 34150709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of plasma vitamin C levels on the risk of cardiovascular diseases and Alzheimer's disease: A Mendelian randomization study.
    Chen L; Sun X; Wang Z; Lu Y; Chen M; He Y; Xu H; Zheng L
    Clin Nutr; 2021 Oct; 40(10):5327-5334. PubMed ID: 34537655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study.
    Manousaki D; Harroud A; Mitchell RE; Ross S; Forgetta V; Timpson NJ; Smith GD; Polychronakos C; Richards JB
    PLoS Med; 2021 Feb; 18(2):e1003536. PubMed ID: 33630834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations.
    Zheng JS; Luan J; Sofianopoulou E; Imamura F; Stewart ID; Day FR; Pietzner M; Wheeler E; Lotta LA; Gundersen TE; Amiano P; Ardanaz E; Chirlaque MD; Fagherazzi G; Franks PW; Kaaks R; Laouali N; Mancini FR; Nilsson PM; Onland-Moret NC; Olsen A; Overvad K; Panico S; Palli D; Ricceri F; Rolandsson O; Spijkerman AMW; Sánchez MJ; Schulze MB; Sala N; Sieri S; Tjønneland A; Tumino R; van der Schouw YT; Weiderpass E; Riboli E; Danesh J; Butterworth AS; Sharp SJ; Langenberg C; Forouhi NG; Wareham NJ
    Diabetes Care; 2021 Jan; 44(1):98-106. PubMed ID: 33203707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation.
    Au Yeung SL; Wong THT; He B; Luo S; Kwok KO
    J Med Virol; 2023 Jan; 95(1):e28205. PubMed ID: 36217700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.